Alison Moore

Chief Technical Officer, Allogene Therapeutics, Inc.

Companies

CodexisChief executive officer Nov 17, 2025 to now¹
CodexisPresident Nov 17, 2025 to now¹
Artiva Biotherapeutics, Inc.Board member Oct 22, 2024 to now²
CodexisChief Technical Officer Oct 10, 2024 to now³
CodexisBoard member Jun 16, 2020 to now⁴
Allogene Therapeutics, Inc.Chief Technical Officer Oct 10, 2018 to Mar 24, 2023⁵

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Feb 6, 2026Sold 3,826 shares at $1.31 of Codexis⁷
Nov 13, 2025Granted 85,000 shares of Codexis⁸
Oct 13, 2025Sold 6,239 shares at $2.51 of Codexis⁹
Feb 5, 2025Granted 26,875 shares of Codexis¹⁰
Oct 10, 2024Granted 50,000 shares of Codexis¹¹
Jun 11, 2024Granted 30,120 shares of Codexis¹²
Jun 13, 2023Granted 34,602 shares of Codexis¹³
Mar 22, 2023Granted 558,094 shares of Allogene Therapeutics, Inc.⁶
Mar 14, 2023Shares withheld for tax 8,351 shares at $5.51 of Allogene Therapeutics, Inc.¹⁴
Jun 14, 2022Granted 11,273 shares of Codexis¹⁵
Mar 15, 2022Sold 8,698 shares at $7.63 of Allogene Therapeutics, Inc.¹⁶

The numbers on this page point here. Each one links to the record it came from.